Abstract
Stromal cell-derived factor 1α (SDF-1α) or CXCL12 is a small pro-inflammatory chemoattractant cytokine and a substrate of dipeptidyl peptidase IV (DPP-IV). Proteolytic cleavage by DPP-IV inactivates SDF-1α and attenuates its interaction with CXCR4, its cell surface receptor. To enable investigation of suppression of such inactivation with pharmacologic inhibition of DPP-IV, we developed quantitative mass spectrometric methods that differentiate intact SDF-1α from its inactive form. Using top-down strategy in quantification, we demonstrated the unique advantage of keeping SDF-1α’s two disulfide bridges intact in the analysis. To achieve the optimal sensitivity required for quantification of intact and truncated SDF-1α at endogenous levels in blood, we coupled nano-flow tandem mass spectrometry with antibody-based affinity enrichment. The assay has a quantitative range of 20 pmol/L to 20 nmol/L in human plasma as well as in rhesus monkey plasma. With only slight modification, the same assay can be used to quantify SDF-1α in mice. Using two in vivo animal studies as examples, we demonstrated that it was critical to differentiate intact SDF-1α from its truncated form in the analysis of biomarkers for pharmacologic inhibition of DPP-IV activity. These novel methods enable translational research on suppression of SDF-1 inactivation with DPP-IV inhibition and can be applied to relevant clinical samples in the future to yield new insights on change of SDF-1α levels in disease settings and in response to therapeutic interventions.
Similar content being viewed by others
References
Ratajczak, M.Z., Zuba-Surma, E., Kucia, M., Reca, R., Wojakowski, W., Ratajczak, J.: The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis. Leukemia 20, 1915–1924 (2006)
Ma, Q., Jones, D., Borghesani, P.R., Segal, R.A., Nagasawa, T., Kishimoto, T., Bronson, R.T., Springer, T.A.: Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 95, 9448–9453 (1998)
Ratajczak, M.Z., Kucia, M., Reca, R., Majka, M., Janowska-Wieczorek, A., Ratajczak, J.: Stem cell plasticity revisited: CXCR4-positive cells expressing mRNA for early muscle, liver, and neural cells ‘hide out’ in the bone marrow. Leukemia 18, 29–40 (2004)
Kryczek, I., Wei, S., Keller, E., Liu, R., Zou, W.: Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis. Am. J. Physiol. Cell Physiol. 292, C987–995 (2007)
Valenzuela-Fernandez, A., Planchenault, T., Baleux, F., Staropoli, I., Le-Barillec, K., Leduc, D., Delaunay, T., Lazarini, F., Virelizier, J.L., Chignard, M., Pidard, D., Arenzana-Seisdedos, F.: Leukocyte elastase negatively regulates Stromal cell-derived factor-1 (SDF-1)/CXCR4 binding and functions by amino-terminal processing of SDF-1 and CXCR4. J. Biol. Chem. 277, 15677–15689 (2002)
Christopherson II, K.W., Hangoc, G., Broxmeyer, H.E.: Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1 alpha-mediated chemotaxis of human cord blood CD34+ progenitor cells. J. Immunol. 169, 7000–7008 (2002)
Proost, P., Struyf, S., Schols, D., Durinx, C., Wuyts, A., Lenaerts, J.-P., De Clercq, E., De Meester, I., Van Damme, J.: Processing by CD26/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor-1α. FEBS Lett. 432, 73–76 (1998)
Yu, L., Cecil, J., Peng, S.-B., Schrementi, J., Kovacevic, S., Paul, D., Su, E.W., Wang, J.: Identification and expression of novel isoforms of human stromal cell-derived factor 1. Gene 374, 174–179 (2006)
De La Luz Sierra, M., Yang, F., Narazaki, M., Salvucci, O., Davis, D., Yarchoan, R., Zhang, H.H., Fales, H., Tosato, G.: Differential processing of stromal-derived factor-1alpha and stromal-derived factor-1beta explains functional diversity. Blood 103, 2452–2459 (2004)
Shioda, T., Kato, H., Ohnishi, Y., Tashiro, K., Ikegawa, M., Nakayama, E.E., Hu, H., Kato, A., Sakai, Y., Liu, H., Honjo, T., Nomoto, A., Iwamoto, A., Morimoto, C., Nagai, Y.: Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha) and SDF-1beta are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage. Proc. Natl. Acad. Sci. U. S. A. 95, 6331–6336 (1998)
Mentlein, R.: Dipeptidyl-peptidase IV (CD26)—role in the inactivation of regulatory peptides. Regul. Pept. 85, 9–24 (1999)
de Meester, I., Lambeir, A.M., Proost, P., Scharpe, S.: Dipeptidyl peptidase IV substrates. An update on in vitro peptide hydrolysis by human DPPIV. Adv. Exp. Med. Biol. 524, 3–17 (2003)
Busso, N., Wagtmann, N., Herling, C., Chobaz-Peclat, V., Bischof-Delaloye, A., So, A., Grouzmann, E.: Circulating CD26 is negatively associated with inflammation in human and experimental arthritis. Am. J. Pathol. 166, 433–442 (2005)
Nelson, R.W., Krone, J.R., Bieber, A.L., Williams, P.: Mass spectrometric immunoassay. Anal. Chem. 67, 1153–1158 (1995)
Anderson, N.L., Anderson, N.G., Haines, L.R., Hardie, D.B., Olafson, R.W., Pearson, T.W.: Mass spectrometric quantitation of peptides and proteins using stable isotope standards and capture by anti-peptide antibodies (SISCAPA). J. Proteome Res. 3, 235–244 (2004)
Nedelkov, D., Kiernan, U.A., Niederkofler, E.E., Tubbs, K.A., Nelson, R.W.: Investigating diversity in human plasma proteins. Proc. Natl. Acad. Sci. U. S. A. 102, 10852–10857 (2005)
Nedelkov, D.: Mass spectrometry-based immunoassays for the next phase of clinical applications. Expert Rev. Proteome 3, 631–640 (2006)
Nedelkov, D., Phillips, D.A., Tubbs, K.A., Nelson, R.W.: Investigation of human protein variants and their frequency in the general population. Mol. Cell. Proteomics 6, 1183–1187 (2007)
Neubert, H., Gale, J., Muirhead, D.: Online high-flow peptide immunoaffinity enrichment and nanoflow LC-MS/MS: assay development for total salivary pepsin/pepsinogen. Clin. Chem. 56, 1413–1423 (2010)
Wang, W., Walker, N.D., Zhu, L.J., Wu, W., Ge, L., Gutstein, D.E., Yates, N.A., Hendrickson, R.C., Ogletree, M.L., Cleary, M., Opiteck, G.J., Chen, Z.: Quantification of circulating D-dimer by peptide immunoaffinity enrichment and tandem mass spectrometry. Anal. Chem. 84, 6891–6898 (2012)
Xu, H., Zhang, L., Freitas, M.A.: Identification and characterization of disulfide bonds in proteins and peptides from tandem MS data by use of the MassMatrix MS/MS search engine. J. Proteome Res. 7, 138–144 (2008)
Huang, Y., Triscari, J.M., Tseng, G.C., Pasa-Tolic, L., Lipton, M.S., Smith, R.D., Wysocki, V.H.: Statistical characterization of the charge state and residue dependence of low-energy CID peptide dissociation patterns. Anal. Chem. 77, 5800–5813 (2005)
Currie, L.A.: Limits for qualitative detection and quantitative determination. Application to radiochemistry. Anal. Chem. 40, 586–593 (1968)
Murphy, A.T., Witcher, D.R., Luan, P., Wroblewski, V.J.: Quantitation of hepcidin from human and mouse serum using liquid chromatography tandem mass spectrometry. Blood 110, 1048–1054 (2007)
Rogatsky, E., Balent, B., Goswami, G., Tomuta, V., Jayatillake, H., Cruikshank, G., Vele, L., Stein, D.T.: Sensitive quantitative analysis of C-peptide in human plasma by 2-dimensional liquid chromatography-mass spectrometry isotope-dilution assay. Clin. Chem. 52, 872–879 (2006)
Nelson, R.W., Nedelkov, D., Tubbs, K.A., Kiernan, U.A.: Quantitative mass spectrometric immunoassay of insulin like growth factor 1. J. Proteome Res. 3, 851–855 (2004)
Niederkofler, E.E., Kiernan, U.A., O’Rear, J., Menon, S., Saghir, S., Protter, A.A., Nelson, R.W., Schellenberger, U.: Detection of endogenous B-type natriuretic peptide at very low concentrations in patients with heart failure. Circ. Heart Fail. 1, 258–264 (2008)
Chappell, D.L., Lee, A.Y.H., Castro-Perez, J., Zhou, H., Roddy, T.P., Lassman, M.E., Shankar, S.S., Yates, N.A., Wang, W., Laterza, O.F.: An ultrasensitive method for the quantitation of active and inactive GLP-1 in human plasma via immunoaffinity LC-MS/MS. Bioanalysis 6, 33–42 (2014)
McQuibban, G.A., Butler, G.S., Gong, J.H., Bendall, L., Power, C., Clark-Lewis, I., Overall, C.M.: Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J. Biol. Chem. 276, 43503–43508 (2001)
Durinx, C., Lambeir, A.M., Bosmans, E., Falmagne, J.B., Berghmans, R., Haemers, A., Scharpe, S., De Meester, I.: Molecular characterization of dipeptidyl peptidase activity in serum: soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides. Eur. J. Biochem. 267, 5608–5613 (2000)
Huber, B.C., Brunner, S., Segeth, A., Nathan, P., Fischer, R., Zaruba, M.M., Vallaster, M., Theiss, H.D., David, R., Gerbitz, A., Franz, W.M.: Parathyroid hormone is a DPP-IV inhibitor and increases SDF-1-driven homing of CXCR4(+) stem cells into the ischaemic heart. Cardiovasc. Res. 90, 529–537 (2011)
Segers, V.F., Tokunou, T., Higgins, L.J., MacGillivray, C., Gannon, J., Lee, R.T.: Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction. Circulation 116, 1683–1692 (2007)
Acknowledgments
The authors thank Aimee L. Burton, Sophie Brennan, Irene Capodanno, and Xiaolan Shen for help with the mouse study. They are grateful for discussions with Joel Berger, David E. Kelley, and Nancy A. Thornberry.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, W., Choi, B.K., Li, W. et al. Quantification of Intact and Truncated Stromal Cell-Derived Factor-1α in Circulation by Immunoaffinity Enrichment and Tandem Mass Spectrometry. J. Am. Soc. Mass Spectrom. 25, 614–625 (2014). https://doi.org/10.1007/s13361-013-0822-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13361-013-0822-7